NCT02897726

A Study to Evaluate the Safety and Pharmacokinetics of NVP-1402

A Clinical Trial to Evaluate the Pharmacokinetics and Safety of NVP-1402 in Healthy Male Subjects

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 38 (actual)
• Sponsor: NVP Healthcare · Industry
• Sex: Male
• Age: 19 Years
• Healthy volunteers: Accepted

Summary

The purpose of this study is to evaluate and compare the safety and pharmacokinetics of NVP-1402 and NVP-1402R in healthy male subjects.

Detailed description

This study is designed as randomized, open-label, active-controlled and crossover assignment for evaluate and compare the safety and pharmacokinetics of NVP-1402 and NVP-1402R in healthy male subjects. The safety assessed through adverse events up to 17 days after administration. Additional variables (ECGs, laboratory test, vital signs, so on) will also be recorded and assessed.

Conditions

• Healthy

Interventions

Type	Name	Description
DRUG	NVP-1402	Oral
DRUG	NVP-1402R	Oral

Timeline

• Start date: 2017-03-24
• Primary completion: 2017-07-03
• Completion: 2017-07-03
• First posted: 2016-09-13
• Last updated: 2017-08-08

Locations

1 site across 1 country: South Korea